STOCK TITAN

FendX Technologies Inc - FDXTF STOCK NEWS

Welcome to our dedicated page for FendX Technologies news (Ticker: FDXTF), a resource for investors and traders seeking the latest updates and insights on FendX Technologies stock.

Company Overview

FendX Technologies Inc. is a Canada-based nanotechnology company dedicated to developing innovative surface protection coatings aimed at reducing the spread of pathogens. Leveraging award-winning nanotechnology licensed from prestigious research institutions, the company has established a strong foundation in using advanced materials to enhance safety in high-touch environments. Its core focus is to design, optimize, and eventually commercialize both film and spray formulations that inhibit pathogen adhesion and transmission, thereby providing safer surfaces for healthcare, transportation, hospitality, and various other industries.

Core Products and Technology

The company is primarily known for its lead product under development, REPELWRAP™ film, a protective coating that utilizes a unique, anti-adhesion nanostructure. This technology has been meticulously engineered to repel bacteria, viruses, and other pathogens from surfaces, thereby reducing contamination risks. Alongside its film product, FendX is also developing an innovative spray coating. This bifunctional spray formulation is designed to not only repel pathogens but also actively kill them upon contact, further enhancing its protective benefits.

R&D and Collaborative Testing Initiatives

FendX Technologies Inc. is committed to rigorous research and development. The company collaborates with leading institutions such as McMaster University to advance its proprietary nanotechnology. Its research activities have focused on refining the formulation, optimizing manufacturing processes in partnership with Dunmore International, and conducting extensive pilot testing. The testing phases cover a range of real-world scenarios—including athletic facilities, senior care centers, and public venues—to validate the effectiveness of the REPELWRAP™ film under various environmental conditions.

Manufacturing and Intellectual Property

Through strategic alliances with manufacturing experts like Dunmore International, FendX has optimized its production process via pilot runs that transition into potential commercial scale production. The company’s robust intellectual property portfolio, which includes exclusive worldwide licenses from McMaster University, underscores its commitment to innovation and protection of its technology. This portfolio not only provides a competitive edge but also establishes the scientific and technical credibility of its products.

Market Position and Competitive Landscape

FendX operates in the dynamic and competitive nanotechnology market, where demand for advanced surface protection solutions is growing. The company differentiates itself by focusing on pathogen reduction through nanotechnology—a field that requires both precise scientific development and innovative commercialization strategies. While many competitors focus on conventional cleaning technologies, FendX emphasizes a paradigm shift towards preventive protection through engineered surface coatings.

Strategic Business Model and Value Proposition

At its core, FendX Technologies Inc. utilizes a business model that integrates continual research and practical manufacturing optimization, enabling transition from lab-scale prototypes to market-ready products. By engaging multiple industry partners for real-world testing, the company is able to gather comprehensive performance data, ensuring its products meet the rigorous demands of different market segments. This multidimensional approach not only highlights the company’s commitment to making environments safer but also positions it as a technology-driven entity in the field of advanced materials.

Conclusion

FendX Technologies Inc. exemplifies the integration of advanced nanotechnology into practical solutions for reducing contamination and enhancing public safety. With its sound research credentials, strategic manufacturing capabilities, and an ever-growing portfolio of intellectual property, the company has established itself as a credible source of innovation in the realm of surface protection. Investors and industry observers can rely on its methodical approach and transparent R&D efforts as it continues to build upon its technological and scientific foundation.

Rhea-AI Summary

FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) highlights a new CDC report showing a 20% increase in infections from six antibiotic-resistant bacteria ('superbugs') in 2021 and 2022 compared to 2019. The CDC attributes this rise partly to COVID-19's impact on healthcare systems, longer hospital stays, and antibiotic overuse.

The report emphasizes the need for more effective infection prevention and control strategies. FendX, a nanotechnology company developing surface protection coatings, aims to contribute to reducing superbug spread. Dr. Carolyn Myers, CEO of FendX, states that the company is dedicated to developing innovative high-touch surface protection solutions to combat superbug transmission and enhance safety.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-31.16%
Tags
none
-
Rhea-AI Summary

FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) has successfully completed a pilot scale-up run of its REPELWRAP™ film with Dunmore International Corp. The company reports that the produced film met performance expectations using a streamlined manufacturing process. Dr. Carolyn Myers, CEO of FendX, expressed satisfaction with the progress and stated that this advancement brings them closer to real-world testing with various industry partners in long-term care, fitness, and entertainment sectors.

FendX plans to conduct another pilot manufacturing run with Dunmore in the coming weeks, which they believe will be the final run before advancing to real-world testing. The company acknowledges the valuable collaboration with Dunmore and McMaster University in reaching this stage. Additionally, FendX granted 55,000 restricted share units (RSUs) to a consultant, vesting in three equal installments over the next three months.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.86%
Tags
none
-
Rhea-AI Summary

FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D), a nanotechnology company developing surface protection coatings, has announced the grant of stock options and restricted share units (RSUs) to certain directors, officers, employees, and consultants. The company granted 3,950,000 stock options at an exercise price of $0.29, expiring in five years, with a vesting schedule of 50% on the grant date and 25% each at nine and eighteen months. Additionally, 1,150,000 RSUs were granted to two officers and a consultant, following the same vesting schedule. These grants are in accordance with the company's equity incentive plan dated October 19, 2021, and are subject to a four-month and one-day hold period from the grant date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.86%
Tags
none
Rhea-AI Summary

FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) has announced plans to conduct real-world testing of its REPELWRAP™ film with LA Fitness at their Vaughan location near Toronto, Ontario. This marks the sixth testing site for FendX's nanotechnology surface protection coating. The company is collaborating with Dunmore International Inc. for pilot manufacturing runs of REPELWRAP™ film.

The testing at LA Fitness will involve applying the film to high-touch surfaces over approximately four weeks to assess its repelling capabilities, as previously demonstrated in McMaster University's lab. This partnership with LA Fitness, a well-established gym chain with 690+ locations across North America, aims to provide valuable insights into the film's performance in a high-traffic environment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.75%
Tags
none
-
Rhea-AI Summary

FendX Technologies Inc. (CSE: FNDX, OTCQB: FDXTF) responded to a request from OTC Markets Group Inc. regarding recent promotional activities related to its common shares. On June 18, 2024, OTC Markets highlighted promotional content distributed by Spartan Trading Inc., an affiliate of Spark Newswire Inc., which FendX had engaged for investor relations and digital marketing services since May 9, 2024. FendX reviewed and commented on this content, which included factual statements about the company. FendX stated it is unaware of any unusual trading activity resulting from this promotion. Furthermore, FendX confirmed that neither its management nor the consultants have engaged in significant trading of the company’s securities in the past 90 days, except for Spartan, which transacted 55,000 shares. FendX reiterated that it is an early-stage issuer with growth objectives yet to be realized and advised investors to review its continuous disclosure filings for comprehensive risk disclosures.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.44%
Tags
none
-
News
Rhea-AI Summary

FendX Technologies, a nanotechnology company specializing in surface protection coatings, has released a corporate update highlighting key milestones and future plans. CEO Dr. Carolyn Myers reported significant advancements in the development and commercialization of the company's REPELWRAP™ film. The automation of the manufacturing process is being optimized through pilot runs, with commercial production expected to begin by the end of 2024. Testing sites for the film include various high-traffic locations such as restaurants and care facilities. The company also announced progress in its medical catheter nano-coating project, which aims to reduce bacterial biofilms and blood clots, and a new spray nanotechnology formulation that's more scalable. Additionally, FendX raised over $2.86M through private placements and warrant exercises. The company continues to build its intellectual property portfolio and seeks further growth through partnerships and acquisitions. Future goals include completing the scale-up of REPELWRAP™, finalizing the spray formulation, and starting proof-of-concept studies for the catheter project.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.56%
Tags
none
Rhea-AI Summary

FendX Technologies announced the initiation of real-world testing for its REPELWRAP™ film with New Vista Society, a non-profit dedicated to senior care and affordable housing. The film, designed for surface protection using nanotechnology, will undergo tests at New Vista's Burnaby, BC facility. The testing will include the application of REPELWRAP™ to high-touch surfaces to observe its repellent performance over four weeks. This marks FendX's fifth testing site, following successful pilot manufacturing runs with Dunmore International.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.8%
Tags
none
-
Rhea-AI Summary

FendX Technologies announced that its nanotechnology product, REPELWRAP™ film, will be featured at the Infection Prevention and Control Canada (IPAC) conference on June 11, 2024. The company's post-doctoral fellow, Dr. Sara Moetakef Imani, will present on the film's capabilities in repelling drug-resistant bacteria and viruses, emphasizing its scalability and potential for enhancing safety in high-touch environments. The IPAC Canada conference provides a platform for highlighting advancements in infection control and public health safety. The film is currently in pilot manufacturing at Dunmore International Corp. for intermediate size real-world testing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

FendX Technologies, a nanotechnology company focused on surface protection coatings to reduce pathogen spread, has started trading on Germany's Tradegate Exchange under the ticker symbol 'E8D'.

This move aims to broaden its investor base and offer European investors easier access to its shares with low transaction costs. Dr. Carolyn Myers, President and CEO, expressed excitement about this development, which complements FendX's existing listings on the Frankfurt Stock Exchange.

Tradegate Exchange, 60% owned by Deutsche Börse AG, is a fully regulated platform facilitating the trading of over 10,000 securities globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.6%
Tags
none
Rhea-AI Summary

FendX Technologies announced plans to conduct real-world testing of its REPELWRAP™ film with Draganfly, a leading drone solutions developer. This collaboration aims to test the film's repelling properties by covering parcel delivery boxes on Draganfly's heavy-lift drones exposed to environmental stresses. Testing results aim to confirm the film's performance, as previously seen in lab settings. Other testing sites include Giulietta, Island View Place Care, and El Mocambo. These diverse environments are expected to contribute valuable insights for the product's final design.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.59%
Tags
none

FAQ

What is the current stock price of FendX Technologies (FDXTF)?

The current stock price of FendX Technologies (FDXTF) is $0.0907 as of March 28, 2025.

What is the market cap of FendX Technologies (FDXTF)?

The market cap of FendX Technologies (FDXTF) is approximately 6.6M.

What is the core business of FendX Technologies Inc.?

FendX Technologies Inc. is a nanotechnology company developing innovative surface protection coatings designed to reduce the spread of pathogens. Their work focuses on both film and spray formulations.

What is REPELWRAP™ film?

REPELWRAP™ film is the company's lead product, a protective coating engineered using advanced nanotechnology to repel bacteria, viruses, and other pathogens from high-touch surfaces.

How does FendX generate revenue?

The company anticipates revenue through eventual commercialization of its patented surface protection products, entering licensing and distribution agreements, and potential manufacturing partnerships with established companies.

What role does research and development play at FendX?

R&D is a critical component of FendX's business model. The company collaborates with industry-leading institutions to refine its nanotechnology, optimize manufacturing processes, and validate product efficacy through real-world testing.

Who are FendX's strategic partners for product testing?

FendX has engaged various industry partners, including manufacturing collaborators like Dunmore International and testing partners across sectors such as healthcare, fitness, and entertainment, to ensure robust real-world validation.

How does FendX protect its technology and innovations?

The company maintains a robust portfolio of intellectual property, including exclusive worldwide licenses from renowned research institutions. This portfolio strengthens its competitive position and protects its proprietary technology.

What industries can benefit from FendX's products?

FendX's surface protection products are applicable to a variety of sectors, including healthcare, transportation, hospitality, senior living facilities, and any setting where high-touch surfaces require robust contamination control.

How is FendX positioned in the competitive landscape?

FendX differentiates itself by focusing on nanotechnology-based pathogen reduction, offering a scientific, R&D-driven approach to surface protection that sets it apart from traditional cleaning or coating solutions.
FendX Technologies Inc

OTC:FDXTF

FDXTF Rankings

FDXTF Stock Data

6.61M
71.10M
2.73%
Specialty Chemicals
Basic Materials
Link
Canada
Oakville